Zimmer Biomet Holdings, Inc. (ZBH)
NYSE$112.91
Market Cap
$22.48B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
922 of 924
Rank in Industry
117 of 118
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
ZBH Insider Trading Activity
ZBH Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $1,625,231 | 2 | 100 |
Related Transactions
| Winkler Lori | SVP and CHRO | 0 | $0 | 1 | $150,649 | $-150,649 |
| Yi Sang | Group President, Asia Pacific | 0 | $0 | 1 | $1.47M | $-1.47M |
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate …
Insider Activity of Zimmer Biomet Holdings, Inc.
Over the last 12 months, insiders at Zimmer Biomet Holdings, Inc. have bought $0 and sold $1.63M worth of Zimmer Biomet Holdings, Inc. stock.
On average, over the past 5 years, insiders at Zimmer Biomet Holdings, Inc. have bought $485,817 and sold $3.96M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,135 shares for transaction amount of $223,641 was made by Jafry Syed A. (director) on 2023‑11‑09.
List of Insider Buy and Sell Transactions, Zimmer Biomet Holdings, Inc.
| 2025-03-05 | Sale | Winkler Lori | SVP and CHRO | 1,443 0.0007% | $104.40 | $150,649 | +4.05% | |
| 2024-05-31 | Sale | Yi Sang | Group President, Asia Pacific | 12,857 0.0062% | $114.69 | $1.47M | -6.15% | |
| 2024-03-07 | Sale | Yi Sang | Group President, Asia Pacific | 1,705 0.0008% | $126.86 | $216,296 | -13.96% | |
| 2024-02-22 | Sale | Phipps Chad F | Sr. VP/Gen Counsel/Secretary | 26,156 0.0125% | $128.62 | $3.36M | -14.08% | |
| 2023-11-09 | Jafry Syed A. | director | 2,135 0.001% | $104.75 | $223,641 | +11.17% | ||
| 2023-08-30 | Kolli Sreelakshmi | director | 1,000 0.0005% | $120.37 | $120,370 | -1.88% | ||
| 2023-08-28 | HAGEMANN ROBERT | director | 2,000 0.0009% | $116.48 | $232,960 | +0.60% | ||
| 2023-08-28 | BEGLEY CHRISTOPHER B | director | 1,000 0.0005% | $117.11 | $117,114 | +0.60% | ||
| 2023-08-25 | BERNARD BETSY J | director | 871 0.0004% | $114.84 | $100,023 | +2.84% | ||
| 2023-08-25 | MICHELSON MICHAEL W | director | 1,300 0.0006% | $115.50 | $150,150 | +2.84% | ||
| 2023-08-23 | HIGGINS ARTHUR J | director | 1,000 0.0005% | $115.61 | $115,613 | +2.94% | ||
| 2023-03-17 | Sale | Phipps Chad F | Sr. VP/Gen Counsel/Secretary | 23,045 0.011% | $124.50 | $2.87M | +0.71% | |
| 2022-12-13 | Sale | Phipps Chad F | Sr. VP/Gen Counsel/Secretary | 11,522 0.0055% | $128.63 | $1.48M | -1.83% | |
| 2022-07-01 | Sale | VAN ZUILEN WILFRED | Pres, Europe, M. East & Africa | 531 0.0002% | $105.22 | $55,870 | +15.99% | |
| 2022-03-17 | Sale | Phipps Chad F | Sr. VP/Gen Counsel/Secretary | 29,518 0.0141% | $121.90 | $3.6M | -2.98% | |
| 2021-12-14 | Sale | Yi Sang | President, Asia Pacific | 5,600 0.0027% | $124.14 | $695,198 | -2.30% | |
| 2021-05-06 | HIGGINS ARTHUR J | director | 2,000 0.0005% | $85.79 | $171,580 | -18.81% | ||
| 2020-11-18 | Sale | Yi Sang | President, Asia Pacific | 2,400 0.0012% | $152.59 | $366,216 | +6.64% | |
| 2020-11-09 | Sale | Phipps Chad F | Sr. VP/Gen Counsel/Secretary | 60,080 0.0149% | $79.85 | $4.8M | +1.34% | |
| 2020-05-29 | Sale | Yi Sang | President, Asia Pacific | 6,000 0.0029% | $125.38 | $752,260 | +17.84% |
Total: 235
*Gray background shows transactions not older than one year
Insider Historical Profitability
6.17%
| Hanson Bryan C | President and CEO | 54568 0.0274% | $6.16M | 6 | 0 | +5.73% |
| GLASSCOCK LARRY C | director | 8593 0.0043% | $970,235.63 | 1 | 4 | +11.99% |
| BERNARD BETSY J | director | 5271 0.0026% | $595,148.61 | 3 | 0 | +5.94% |
| HAGEMANN ROBERT | director | 4000 0.002% | $451,640.00 | 2 | 0 | +7.28% |
| Jafry Syed A. | director | 4060 0.002% | $458,414.60 | 2 | 0 | +10.1% |
ZBH Institutional Investors: Active Positions
| Increased Positions | 454 | +40.07% | 17M | +9.22% |
| Decreased Positions | 463 | -40.86% | 16M | -8.78% |
| New Positions | 144 | New | 4M | New |
| Sold Out Positions | 94 | Sold Out | 1M | Sold Out |
| Total Postitions | 1,124 | -0.79% | 182M | +0.44% |
ZBH Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $2.52M | 11.5% | 22.89M | -398,676 | -1.71% | 2024-12-31 |
| Dodge & Cox | $2.1M | 9.61% | 19.12M | +2M | +11.97% | 2024-12-31 |
| Blackrock, Inc. | $1.77M | 8.11% | 16.13M | -562,906 | -3.37% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $1.62M | 7.42% | 14.76M | +176,337 | +1.21% | 2024-12-31 |
| State Street Corp | $987,979.00 | 4.51% | 8.98M | -99,805 | -1.1% | 2024-12-31 |
| American Century Companies Inc | $651,176.00 | 2.98% | 5.92M | -621,555 | -9.5% | 2024-12-31 |
| Geode Capital Management, Llc | $536,331.00 | 2.45% | 4.88M | -2,323 | -0.05% | 2024-12-31 |
| Primecap Management Co/Ca/ | $527,543.00 | 2.41% | 4.8M | -174,230 | -3.5% | 2024-12-31 |
| Invesco Ltd. | $468,883.00 | 2.14% | 4.26M | -97,468 | -2.23% | 2024-12-31 |
| Van Eck Associates Corp | $434,981.00 | 1.99% | 3.96M | +218,688 | +5.85% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.